Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000902664-25-000808·HIGHBRIDGE CAPITAL MANAGEMENT LLC
Schedule 13G ownership disclosure
INOVIO PHARMACEUTICALS INC
Common Stock, par value $0.001 per share · CUSIP: 45773H409
Event date: 2024-12-31
- Filing-level shares
- 3,633,333.00
- Percent of class
- 9.2%
- Highbridge Capital Management, LLC
Shares: 3,633,333.00 · Class: 9.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-000808
- Form type
- SCHEDULE 13G
- Filer
- HIGHBRIDGE CAPITAL MANAGEMENT LLC
- CIK
- CIK 919185
- Filed
- Feb 10, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership